Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

被引：0

作者：

Zhang, Yi ^{[1
]}

Zhou, Hu ^{[2
]}

Suo, Shanshan ^{[1
]}

Zhuang, Junling ^{[3
]}

Yang, Linhua ^{[4
]}

He, Aili ^{[5
]}

Liu, Qingchi ^{[6
]}

Du, Xin ^{[7
]}

Gao, Sujun ^{[8
]}

Li, Yarong ^{[9
]}

Li, Yan ^{[10
]}

Chen, Yuqing ^{[11
]}

Wu, Wen ^{[12
]}

Zhu, Huanling ^{[13
]}

He, Guangsheng ^{[14
]}

Hong, Mei ^{[15
]}

Jiang, Qian ^{[16
]}

Jiang, Zhongxing ^{[17
]}

Jing, Hongmei ^{[18
]}

Wang, Jishi ^{[19
]}

Xu, Na ^{[20
]}

Yue, Lingling ^{[21
]}

Zheng, Cuiping ^{[22
]}

Zhou, Zeping ^{[23
]}

Jin, Chenghao ^{[24
]}

Li, Xin ^{[25
]}

Liu, Lin ^{[26
]}

Xu, Yajing ^{[27
]}

Wu, Dengshu ^{[28
]}

Zhang, Feng ^{[29
]}

Zhang, Jin ^{[30
]}

Xiao, Zhijian ^{[31
]}

Jin, Jie ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China

[2] Henan Prov Hematol Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China

[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China

[4] Second Hosp Shanxi Med Univ, Neurosurg, Taiyuan, Peoples R China

[5] Xi An Jiao Tong Univ, Dept Neurol, Affiliated Hosp 2, Xian, Peoples R China

[6] Hebei Med Univ, Hosp 1, Shijiazhuang, Peoples R China

[7] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Hematol, Guangzhou, Peoples R China

[8] First Hosp Jilin Univ, Dept Hematol, Changchun, Peoples R China

[9] Second Hosp Jilin Univ, Dept Hematol & Oncol, Changchun, Peoples R China

[10] China Med Univ, Affiliated Hosp 1, Dept Hematopathol, Shenyang, Peoples R China

[11] Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China

[12] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom,Ruijin Hosp,Sch Med, Shanghai, Peoples R China

[13] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China

[14] Nanjing Med Univ, Key Lab Hematol, Jiangsu Prov Hosp, Collaborat Innovat Ctr Canc Personalize,Affiliated, Nanjing, Peoples R China

[15] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[16] Peking Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Peoples Hosp, Beijing, Peoples R China

[17] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[18] Peking Univ Third Hosp, Beijing, Peoples R China

[19] GuiZhou Med Univ, Dept Hematol, Affiliated Hosp, Guiyang City, Peoples R China

[20] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China

[21] Lanzhou Univ Second Hosp, Dept Hematol & Oncol, Lanzhou, Peoples R China

[22] Wenzhou Cent Hosp, Dept Oncol 2, Wenzhou, Peoples R China

[23] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China

[24] Jiangxi Prov Peoples Hosp, Nanchang, Peoples R China

[25] Cent South Univ, Third Xiangya Hosp, Dept Hematol, Changsha, Peoples R China

[26] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China

[27] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[28] Cent South Univ, Xiangya Hosp, Dept Hematol, Changsha, Peoples R China

[29] Bengbu Med Coll, Affiliated Hosp 1, Dept Hematol, Bengbu, Peoples R China

[30] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Hematol, Hangzhou, Peoples R China

[31] Chinese Acad Med Sci & Peking Union Med Coll, MDS & MPN Ctr, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-202790

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3165 / 3166

页数：2

共 50 条

[41] What is the minimally clinically important difference in negative symptoms of schizophrenia? PANSS based post hoc analyses of a phase III clinical trial
Barabassy, A.
Acsai, K.
Laszlovszky, I.
Szatmari, B.
Harsanyi, J.
Sebe, B.
Earley, W.
Patel, M.
Nemeth, G.
EUROPEAN PSYCHIATRY, 2019, 56 : S247 - S247
[42] COMPARING THE EFFECT OF NOVOTTF TO BEVACIZUMAB IN RECURRENT GBM: A POST-HOC SUB-ANALYSIS OF THE PHASE III TRIAL DATA
Ram, Zvi
Wong, Eric T.
Gutin, Philip H.
NEURO-ONCOLOGY, 2011, 13 : 52 - 52
[43] Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Post Hoc Analysis
Chang, Shun-Cheng
Lin, Ching-Wen
Chen, Jui-Ching
Wu, Yi-Hsin
Chen, Shyi-Gen
Huang, Yu-Yao
Cheng, Nai-Chen
Cazzell, Shawn M.
Chen, Hsin-Han
Huang, Kuo-Feng
Tung, Kwang-Yi
Huang, Hsuan-Li
Perng, Cherng-Kang
Shi, Bimin
Liu, Chang
Ma, Yujin
Cao, Yemin
Li, Yanbing
Xue, Yaoming
Gao, Fang
Cao, Ying
Yan, Li
Li, Qiu
Armstrong, David G.
Ning, Guang
ADVANCES IN WOUND CARE, 2024,
[44] The Effects of Pantoprazole on Kidney Outcomes: Post Hoc Observational Analysis from the COMPASS Trial
Pyne, Lonnie
Smyth, Andrew
Molnar, Amber O.
Moayyedi, Paul
Muehlhofer, Eva
Yusuf, Salim
Eikelboom, John
Bosch, Jacqueline
Walsh, Michael
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (07): : 901 - 909
[45] Prestroke and Poststroke Sulfonylurea Exposure and Functional Outcomes: A Post Hoc Analysis of the SHINE Trial
Shu, Liqi
Zhang, Wenyuan
Yaghi, Shadi
Grilli, Anais
de Havenon, Adam
Barrett, Kevin M.
Johnston, Karen C.
Goldstein, Eric D.
STROKE, 2023, 54 (09) : E415 - E416
[46] The Effect of Patient Sex on Treatment Outcomes in COPD: A Post Hoc Analysis of the IMPACT Trial
Alberola, Alejandra Hernandez
Nogal, Natalia Bartolome
Miranda, Almudena Blanco
Lipson, David A.
Tombs, Lee
Han, MeiLan K.
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2024, 11 (06): : 591 - 603
[47] The efficacy of cariprazine in chronic schizophrenia - post hoc analyses of phase II/III clinical trials
Falkai, P.
Dombi, Z.
Acsai, K.
Barabassy, A.
Nemeth, G.
EUROPEAN PSYCHIATRY, 2022, 65 : S323 - S323
[48] Smoking and Outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial
Weinrauch, Larry A.
Claggett, Brian
Liu, Jiankang
Finn, Peter V.
Weir, Matthew R.
Weiner, Daniel E.
D'Elia, John A.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2018, 11 : 155 - 164
[49] Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial
Miles, D.
Im, Y. -H
Fung, A.
Yoo, B.
Knott, A.
Heeson, S.
Beattie, M. S.
Swain, S. M.
ANNALS OF ONCOLOGY, 2017, 28 (11) : 2761 - 2767
[50] Predictors of Clinical Response to Intravenous Secukinumab Among Patients with Axial Spondyloarthritis: A Post Hoc Analysis of a Phase 3 Trial
Deodhar, Atul
Dokoupilova, Eva
Vizcaya, Cynthia
Sutariya, Reema
Bao, Weibin
Kapur, Karen
Rohrer, Susanne
Kivitz, Alan
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3020 - 3023

← 1 2 3 4 5 →